Imperial Valley News Center
Washington, DC - The U.S. Department of Energy (DOE) announced $1.87 million for seven projects to advance innovation in U.S. manufacturing through high performance computing. Part of DOE's High Performance Computing for Manufacturing (HPC4Mfg) program, the seven new public private partnerships will enable greater collaboration between DOE national labs and the U.S. manufacturing industry.
FDA warns Becton Dickinson & Company of significant violations of the law as part of ongoing investigation into lead testing issues
Washington, DC - The U.S. Food and Drug Administration Thursday issued a warning letter to Becton Dickinson (BD) & Company that cited several violations of federal law, including marketing significantly modified versions of certain BD Vacutainer blood collection tubes without required FDA clearance or approval and failing to submit medical device reports to the FDA within the required timeframe. These violations were discovered through an inspection of BD’s New Jersey facility. The inspection also showed that the company failed to evaluate and investigate a complaint involving variability in test results observed when certain BD Vacutainer blood collection tubes were used with Magellan Diagnostics’ LeadCare test systems.
Washington, DC - Food Tank has gathered the latest books for Winter 2018 to feed your voracious appetite for reading! From North America’s fisheries and oceans to Australia’s sunburned landscapes and regenerative farmers, these books cover a range of themes. Discover the growing movements for land and culinary justice, how capitalism shapes the food system, or how to incorporate insects into a dessert menu. Whether you’re looking for inspiration in the kitchen or beginning your journey as a food activist, there are plenty of great books below to choose from to help feed your imagination.
FDA acts to protect kids from serious risks of opioid ingredients contained in some prescription cough and cold products
Washington, DC - The U.S. Food and Drug Administration announced Thursday that it is requiring safety labeling changes to limit the use of prescription opioid cough and cold medicines containing codeine or hydrocodone in children younger than 18 years old because the serious risks of these medicines outweigh their potential benefits in this population. After safety labeling changes are made, these products will no longer be indicated for use to treat cough in any pediatric population and will be labeled for use only in adults aged 18 years and older. Labeling for the medications also is being updated with additional safety information for adult use – including an expanded Boxed Warning, the FDA’s most prominent warning ‒ notifying about the risks of misuse, abuse, addiction, overdose and death, and slowed or difficult breathing that can result from exposure to codeine or hydrocodone.
Marketers Barred from Making Deceptive Claims about Products Ability to Mitigate Side Effects of Cancer Treatment
Washington, DC - CellMark Biopharma, LLC and its CEO have agreed to settle Federal Trade Commission charges that they made false or unsupported claims regarding two health products they marketed as effective treatments for cancer patients’ malnutrition and “chemo fog,” or treatment-related cognitive dysfunction.
Sacramento, California - Governor Brown’s proposed budget of $488 million for the California Department of Food and Agriculture for 2018-2019 reflects his emphasis on steady growth while maintaining a sufficient rainy day fund.
Page 2 of 2210